Warning: The NCBI web site requires JavaScript to function. more...
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
Hancock MM, Prosser CC, Ransibrahmanakul K, Lester L, Craemer E, Bourgeois JA, Rossaro L.
Subst Abuse Treat Prev Policy. 2007 Feb 1;2:5.
Related citations
A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients.
Weinrieb RM, Barnett R, Lynch KG, DePiano M, Atanda A, Olthoff KM.
Liver Transpl. 2004 Jan;10(1):97-106.
Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).
Salsitz EA, Joseph H, Frank B, Perez J, Richman BL, Salomon N, Kalin MF, Novick DM.
Mt Sinai J Med. 2000 Oct-Nov;67(5-6):388-97.
Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
Nair S, Lipscomb J, Eason J.
Transplantation. 2008 Aug 15;86(3):418-22.
An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
Rubin A, Berenguer M.
Liver Transpl. 2010 Jun;16(6):697-700. No abstract available.
Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.
Kornberg A, Küpper B, Tannapfel A, Thrum K, Bärthel E, Habrecht O, Settmacher U.
Transplantation. 2008 Aug 15;86(3):469-73.
The impact of hepatitis C virus infection on methadone maintenance treatment.
Novick DM.
Mt Sinai J Med. 2000 Oct-Nov;67(5-6):437-43. Review.
[The recurrence of hepatitis C virus after liver transplantation].
Nemes B, Sárváry E, Gerlei Z, Fazakas J, Doros A, Németh A, Görög D, Fehérvári I, Máthé Z, Gálffy Z, Pár A, Schuller J, Telegdy L, Fehér J, Lotz G, Schaff Z, Nagy P, Járay J, Lengyel G.
Orv Hetil. 2007 Oct 21;148(42):1971-9. Hungarian.
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Castells L, Esteban JI, Bilbao I, Vargas V, Allende H, Ribera E, Piron M, Sauleda S, Len O, Pahissa A, Esteban R, Guardia J, Margarit C.
Antivir Ther. 2006;11(8):1061-70.
Hepatitis C therapy before and after liver transplantation.
Terrault NA.
Liver Transpl. 2008 Oct;14 Suppl 2:S58-66. Review.
[Quality assurance in patient addiction treated with drug substitution].
[No authors listed]
Krankenpfl J. 2005;43(7-10):248. German. No abstract available.
Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
Iacob S, Gheorghe L, Hrehoret D, Becheanu G, Herlea V, Popescu I.
J Gastrointestin Liver Dis. 2008 Jun;17(2):165-72.
Liver transplantation for hepatitis C.
Marubashi S, Dono K, Miyamoto A, Takeda Y, Nagano H, Umeshita K, Monden M.
J Hepatobiliary Pancreat Surg. 2006;13(5):382-92. Review.
Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?
Bizollon T, Trepo C.
J Hepatol. 2002 Aug;37(2):274-6. Review. No abstract available.
Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
Kwo PY, Saxena R, Cummings OW, Tector AJ.
Liver Transpl. 2007 Dec;13(12):1710-3.
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
Brown LS Jr, Kritz S, Chu M, Madray C.
J Subst Abuse Treat. 2006 Jun;30(4):331-5.
Liver transplantation and opioid dependence.
Koch M, Banys P.
JAMA. 2001 Feb 28;285(8):1056-8. No abstract available.
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
Novick DM, Kreek MJ.
Addiction. 2008 Jun;103(6):905-18. Epub 2008 Apr 16. Review.
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
Schmitz V, Kiessling A, Bahra M, Puhl G, Kahl A, Berg T, Neuhaus R, Neuhaus P, Neumann U.
Ann Transplant. 2007;12(3):22-7.
[The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
Horváth G, Tolvaj G, Halász T, Stotz G.
Orv Hetil. 2007 Aug 19;148(33):1545-50. Hungarian.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on